Literature DB >> 6128517

Cyclosporin, methylprednisolone, and convulsions.

M A Boogaerts, P Zachee, R L Verwilghen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6128517     DOI： 10.1016/s0140-6736(82)91229-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation.

Authors:  Walter S Bartynski; Zella R Zeigler; Richard K Shadduck; John Lister
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 2.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

3.  Cyclosporin A: pharmacologic activity on the immune system and effects in clinical organ transplantation.

Authors:  L H Block; P M Sutter; M J Mihatsch
Journal:  Klin Wochenschr       Date:  1983-11-02

4.  Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity.

Authors:  W S Bartynski; Z Zeigler; M P Spearman; L Lin; R K Shadduck; J Lister
Journal:  AJNR Am J Neuroradiol       Date:  2001 Nov-Dec       Impact factor: 3.825

Review 5.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

6.  Cyclosporin A toxicity: MRI appearance of the brain.

Authors:  M T Pace; T L Slovis; J K Kelly; S D Abella
Journal:  Pediatr Radiol       Date:  1995

7.  Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation.

Authors:  Walter S Bartynski; Zella R Zeigler; Richard K Shadduck; John Lister
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

8.  CNS aspergillosis in organ transplantation: a clinicopathological study.

Authors:  J Torre-Cisneros; O L Lopez; S Kusne; A J Martinez; T E Starzl; R L Simmons; M Martin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

Review 9.  Clinical pharmacokinetics of cyclosporin.

Authors:  R J Ptachcinski; R Venkataramanan; G J Burckart
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

Review 10.  Practical aspects in the use of cyclosporin in paediatric nephrology.

Authors:  P F Hoyer; J Brodehl; J H Ehrich; G Offner
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.